statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IGM Biosciences Refocuses Genzyme Collaboration on Immunology

IGM Biosciences (IGMS) has shared an update. IGM Biosciences, Inc. has shifted its collaboration with Genzyme Corporation to focus solely on immuno...

In-Depth Examination Of 6 Analyst Recommendations For IGM Biosciences

Latest Ratings for IGMS
 DateFirmActionFromTo Dec 2021HC Wainwright & Co.MaintainsBuy Dec 2021Morgan StanleyDowngradesOverweightEqual-Weight Dec 2021StifelMaintainsBuy
 View More Analyst Ratings...

IGM Biosciences Upgraded to Buy: What Does It Mean for the Stock?

Investors might want to bet on IGM Biosciences, Inc. (NASDAQ: IGMS), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful...

Short Interest in IGM Biosciences, Inc. (NASDAQ:IGMS) Rises By 5.5%

IGM Biosciences, Inc. (NASDAQ:IGMS - Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 4,760,000...

Commit To Buy IGM Biosciences At $5, Earn 21.6% Annualized Using Options

Investors considering a purchase of IGM Biosciences Inc (IGMS) stock, but tentative about paying the going market price of 9.38/share, might benefit from considering selling puts among the...

IGM Biosciences (IGMS, $9.45) Aroon Indicator entered a Downtrend on April 01, 2024.

For the last three days, A.I.dvisor has detected that IGMS's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Insider Buying: IGM Biosciences, Inc. (NASDAQ:IGMS) Director Purchases $2,230,200.00 in Stock

IGM Biosciences, Inc. (NASDAQ:IGMS - Get Free Report) Director Bros. Advisors Lp Baker acquired 270,000 shares of the company's stock in a transaction that occurred on Tuesday, March 26th. The shares...

IGM Biosciences (IGMS, $9.65) Aroon Indicator entered a Downtrend on March 28, 2024.

IGM Biosciences (IGMS, $9.29) RSI Indicator left the oversold zone on March 27, 2024

This is a signal that IGMS's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

IGM Biosciences (IGMS, $9.29) Aroon Indicator entered a Downtrend on March 27, 2024.

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies. The firm’s product pipeline includes IGM-2323, which is a CD20 x CD3 bispecific IgM antibody designed to treat patients with B cell Non-Hodgkin's lymphoma and other B cell malignancies, IGM-8444, which is an IgM antibody targeting Death Receptor 5 for the treatment of patients with solid and hematologic malignancies, and IGM-7354, which will target the delivery of IL-15 with the goal of inducing immune cell stimulation and proliferation. The company was founded in 2010 and is headquartered in Mountain View, CA.

Volume	359,253.00
52-Wk High	$17.70
52-Wk Low	$3.81

IGMS IGM Biosciences Inc

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community